Ceapro Inc V.CZO

If Ceapro needed funding…..

[lscfa]

It could have merged with a Nasdaq-listed SPAC. This would have given it cash, US listing and no drag from AEZS biz.  A SPAC merger would have likely valued CZO higher than its current market cap.


https://www.stockwatch.com/News/Item/Z-C!FH-3434568/C/FH

[prophetoffactz]

AEZS's diagnostic test isn't a drag. It could be a very important source of upfront capital and future royalty revenue based on the previous Strongbridge, and Novo Nordisk deals as well as given the H.C. Wainwright target which is probably diagnostic test driven. AEZS also has pipeline assets now before go/no go clinical trial decisions that can be licensed. In a falling interest rate

[Ciao]

but they don't as per their Q3 earnings report... and if they did, there are lots of opportunities to raise funds by finding commercial interests for their pipeline...Avalyn raised $175M USD in the fall for their IPF pipeline, CEAPRO could do something similar with Y-BG which is of course on "hold", pending, oh by the way, we should have done toxicology testing first...before

[Hopeforthebest]

I will bet you you $100, that gagnon never pursued funding from an out source as he never has and will never give up control unless he is voted out. By allowing for outsource fund would rest in more scrutiny and loss of power. This entire merger and wanting to be on the Nasdaq is just a red herring put out by gagnon to legitimize this sham merger with Aezs, and thereby giving him more power and

[Ciao]

No scrutiny by anyone outside CEAPRO and no accountability by a friendly board, shareholders, fund managers, and no customers, no partners, etc. The only deals he makes are with vendors. And a Mickey Mouse arms length deal is all he is capable of doing with a cash burning biopharma where he left the CEO position, only to rejoin the board 3 years ago. What a blatant disregard for "valued"